MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer-Reference-Cited by-同舟云学术

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Published:2022-10 Issue:10 Volume:40 Page:1128-1144.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Kitajima Shunsuke,Tani Tetsuo,Springer Benjamin F.,Campisi Marco,Osaki Tatsuya^ORCID,Haratani Koji,Chen Minyue,Knelson Erik H.^ORCID,Mahadevan Navin R.^ORCID,Ritter Jessica,Yoshida Ryohei^ORCID,Köhler Jens,Ogino Atsuko^ORCID,Nozawa Ryu-Suke,Sundararaman Shriram K.,Thai Tran C.,Homme Mizuki,Piel Brandon,Kivlehan Sophie,Obua Bonje N.,Purcell Connor,Yajima Mamiko^ORCID,Barbie Thanh U.,Lizotte Patrick H.^ORCID,Jänne Pasi A.,Paweletz Cloud P.,Gokhale Prafulla C.,Barbie David A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference66 articles.

1. STING agonists as cancer therapeutics;Amouzegar;Cancers (Basel),2021

2. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade;Aref;Lab Chip,2018

3. QuPath: open source software for digital pathology image analysis;Bankhead;Sci. Rep.,2017

4. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations;Bleau;Int. J. Cancer,2014

5. Tumor-derived cGAMP regulates activation of the vasculature;Campisi;Front. Immunol.,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I;Journal of Translational Medicine;2024-08-14

3. The balance of STING signaling orchestrates immunity in cancer;Nature Immunology;2024-06-25

4. TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING;JCI Insight;2024-06-20

5. Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities;Trends in Pharmacological Sciences;2024-06